Revalor H
$759.00
Each implant contains:
Trenbolone acetate 200 mg
17β estradiol 20 mg
Excipient, q.s. 1 implant (with 10 tablets)
INDICATIONS: Growth promoter for finishing female cattle in feedlots, with a duration of 120 to 140 days. It increases daily weight gain, improves feed conversion, reduces the fattening period, and improves cattle conformation.
PHARMACEUTICAL FORM:
Implants or cartridges.
PHARMACODYNAMIC PROPERTIES:
Trenbolone acetate is a synthetic androgen that exhibits strong anabolic and weak androgenic activity. 17β-Estradiol is an analog of the endogenous steroid.
Its activity at the tissue level (muscle and fat tissue) results from: i) a direct action on target tissues (particularly muscle cells, through binding to specific intracellular receptors) and ii) an indirect action through alterations in the concentrations of other anabolic and catabolic hormones, such as growth hormone, insulin, insulin-like growth factor 1, and glucocorticoids. This results in increased protein deposition and, therefore, improved growth performance in heifers. This is the basis for the use of trenbolone acetate and 17β-estradiol to promote growth.
PHARMACOKINETIC PROPERTIES:
Following implantation, trenbolone acetate and 17β-estradiol are gradually released over a typical treatment period.
DOSAGE AND ADMINISTRATION:
Administer one implant (10 tablets) subcutaneously in the middle third of the posterior surface of the animal's ear.
